¡°	sumatriptan monotherapy	11.348518603542558
¡°	naproxen sodium	11.345178365669643
¡°	additional sumatriptan	10.537697300449716
¡°	naproxen present	7.522556969522797
¡°	sumatriptan nsaid	7.440724401470501
	5-ht agonist	7.213403194231128
¡°	patient sumatriptan	7.058517243572596
	expert	6.326170330371437
	migraine symptom	5.384699795590734
	migraine relief	5.256120687168863
	reduce migraine relapse	3.9155944379842484
	5-ht receptor agonist	3.639470056454239
	total triptan present	3.5084664979080755
	various migraine treatment	3.5077200380056888
	Migraine	3.2404594959372623
	migraine headache patient	2.8965885966678755
	Treximet	2.701243822358527
	migraine patient	2.649732075360274
	Parma Reference	2.5910182838914184
	Catarci Reference	2.5910182838914184
	Parma reference	2.5139546500540315
	Catarci reference	2.5139546500540315
	LA NSAID	2.3667715887219365
	Saadah Reference	2.233250757159215
	patient daily migraine	2.1932579104325147
	metoclopramide	2.16168437083246
	Saadah reference	2.156187123321828
	multilayer tablet	2.0428484004256187
	Sumatriptan Daily Intake	1.9447595889320966
	either NSAID	1.8394684838066861
	patient acute migraine attack	1.8390398023691488
	Oral Naproxen Sodium	1.6363039888806614
	antiemetic	1.6217807027272413
	acupuncture	1.6217807027272413
	multilayer pharmaceutical tablet	1.5514358049643955
	widely use anti migraine agent	1.5494619053294296
	concomitant administration	1.5490364415528481
	list FANS	1.484339085095617
	ergotamine induce headache	1.4679336037386004
	plus Ergotamine	1.3620635717280096
	daily NSAID	1.3487632320991427
	caffeine	1.2469167000536279
	Laboratories Inc. collectively	1.083465831018585
	Pharmacologic Rationale	1.0815323785702788
	New Hampshire Raskin acute Prophylactic Treatment	0.8413939430522394
	Ergotamine induced headache	0.7610667132578038
	Practical Approaches	0.7582087536005644
	term dissolution	0.696036698043706
	nausea	0.6521194589189419
	Caffeine	0.6238564716867835
	Henry Ford Records	0.5902335046215262
	Henry Ford Hospital	0.5792912633730869
	Henry Ford Patient Records	0.5756310838536393
	plus Metoclopramide	0.5522078498338856
	various monotherapy treatment	0.548769247221042
	Tognoni declaration	0.5426815727447706
	States.1	0.5409389580475604
	partnership	0.5409389580475604
	Medicine".6	0.5409389580475604
	NSAIDs	0.5409389580475604
	Monotherapy	0.5409389580475604
	Analgesics	0.5409389580475604
	Detroit	0.5409389580475604
	labeling	0.5237934177589384
	daily administration	0.4873887974978182
	offering	0.4348851286308499
	single tablet	0.4242170313768369
	simultaneous administration	0.37707756769877004
	second layer	0.3764786046638934
	simultaneous sequential administration	0.3365815056097913
	onset	0.32956229940861903
	long act nsaid	0.31224642636119104
	anda	0.3007961979297004
	drug induce daily headache	0.29959963283290547
	Henry Ford Clinic	0.29778277333315994
	constant mild headache	0.29027244082599835
	Unsatisfactory treatment	0.28249171461276684
	references.4	0.276129532056506
	GSK	0.2704694790237802
	one distinct layer	0.25719492566083807
	single drug administration entity(y	0.25269202783578304
	first layer	0.25096499418731494
	container	0.25026461154590435
	table VIII	0.24844748542844436
	epidemiological survey	0.22400426513408678
	gastric emptying	0.22400426513408678
	daily dose	0.21782394955459927
	prophylactic treatment	0.21596698095491892
	Table VIII	0.21166514944494683
	Zenon Envtl	0.19457083416686333
	second distinct layer	0.19291179390127108
	Therapeutic Equivalence Evaluations	0.19139185604765463
	precursor symptom	0.1891737678646183
	unsatisfactory treatment	0.1870877592468102
	simultaneous delivery	0.18376226082729655
	unlicensed manufacture	0.1804854121409172
	unsatisfactory result	0.17907814964197907
	italian abbreviation	0.17651330940719553
	GlaxoSmithKline	0.16483379544265042
	co timely administration	0.1566985228060787
	predicable result	0.15602178341756898
	second separate layer	0.15083530229180728
	patient prescription	0.1486202259312488
	analgesic anti inflammatory effect	0.14750411829646504
	well know nonsteroidal anti inflammatory drug	0.14345614616854682
	therapeutic package	0.13379036973209904
	Crocs	0.1310738373546999
	daily basis	0.12247509424127186
	various dosage	0.10760796943454022
	Gurley	0.10758101962895099
	Conclusion	0.10758101962895099
	respective ANDA product	0.10327720243331762
	single dose	0.0954215711844739
	unit dose form	0.09296844317410786
	Orange Book	0.08570163673879834
	longer last efficacy	0.08131817663092743
	ANDA filing	0.0802493094439291
	b long act non steroidal anti inflammatory drug	0.0771288425361719
	another table	0.06814610414622788
	concentration	0.0664150943537525
	another agent	0.06554601200873243
	either agent	0.06539823510986716
	one agent	0.06539397531013715
	unit dose limitation	0.06199193207837775
	oral unit dosage form	0.060477849799639403
	doctor	0.05835046571852664
	two drug	0.05747542194889562
	Abbreviated New Drug Application ANDA product	0.0565677540773679
	percentage	0.05492329993810533
	beneficial effect	0.04999671524850755
	efficacy benefit	0.04870235716417666
	Joint Appendix	0.04861706439455036
	pain inflammation reduction effect	0.04806321817253862
	remain efficacy limitation	0.04748275622736448
	J.A	0.04515658524212017
	two agent	0.04359602361133707
	close enough temporal proximity	0.04228023657836024
	fifteen drug combination	0.04184540138716506
	FDA approval	0.040573039125764515
	various drug combination	0.03879480633465789
	second drug	0.038337707435541456
	first drug	0.03831696518026082
	FDA Approved Drug Products	0.03822657987023046
	Leonard Davis	0.03816599874232682
	effective medicine	0.037012732142612484
	single patient	0.03348311399033821
	two patient record	0.03343247062150619
	Lupin	0.03324873342713218
	Michigan	0.03324873342713218
	artificial act	0.03103996553861757
	enjoin competitor	0.030799574344511898
	one hour	0.030650066005994334
	i4i Ltd. p'ship	0.028912066761900945
	generic pharmaceutical manufacturer	0.02873475985181397
	pharmaceutical composition	0.028699347226388377
	combination therapy	0.027769927079459758
	individual therapeutic effect	0.027563509703322223
	D. Procedural history	0.023144193909326257
	least hour	0.02304357095508791
	pharmacokinetic half life	0.022377285178302214
	equivalent	0.021363684516021154
	someone	0.021132228275693412
	treatment plan	0.020986743542714844
	therapeutically effective amount	0.02068465783140902
	side arrangement	0.020307933169280756
	General	0.020139475023322136
	Mylan Labs.	0.019980473790383285
	well absorption	0.018404493727195253
	effective plasma level	0.015508484910309879
	one unit	0.01429194509286638
	Phillips	0.01371937248525924
	permanent injunction	0.012356186614040013
	Texas	0.011448966847379043
	lawsuit	0.010566114137846706
	Microsoft Corp.	0.010264535553466817
	certification	0.009156807969606969
	Review	0.008829882630938111
	various combination treatment	0.008492722978617435
	effective treatment	0.006875413018568543
	iii	0.00686187783582871
	i.	0.006500885203813794
	supra	0.006455752809593631
	harmless error	0.0062161346295712015
	doctrine	0.006194234611341785
	effectiveness	0.005989786407119931
	study	0.005724483423689522
	respective amount	0.005008478993028747
	unenforceability defense	0.003928386305197706
	internal quotation mark	0.003917855380661931
	generic form	0.003838832450869422
	skilled artisan	0.003608180135742495
	complaint	0.0034337591300666534
	fashion	0.003357657363043724
	Obviousness	0.0029704624183862663
	counterclaim	0.0029186267032163087
	generic product	0.002645970924416863
	motivation	0.002553571686782717
	improvement	0.0019176393795435768
	illustrate	0.0019176393795435768
	another article	0.001799672828166719
	Eastern District	0.0017483313530035685
	Teleflex Inc.	0.0017168795650333267
	add benefit	0.0017030513344241662
	internal citation	0.0014534997545281303
	five day bench trial	0.0014097574386767358
	April	0.0014061134313825665
	commercial success	0.001387218367505729
	anything	0.001343046828309173
	Int'l Trade Comm'n	0.0013427496723213718
	case report	0.0013421982482747002
	relative success	0.0013286964032163994
	presumption	0.0011245751894530434
	one solution	0.0010987752399500765
	establish function	0.000816811190506959
	different solution	0.0007427118103312216
	three related	0.00071400669661352
	entirely different combination	0.0006565562081504417
	none	0.0006370838278539969
	construction hearing	0.0006127218928445325
	content	0.0006043925849007106
	several component	0.0005936784247872085
	discretion	0.0005535838714311808
	meaning	0.0005074646326931072
	representative	0.0004974473872833513
	initial matter	0.00047089371495958574
	write description requirement	0.0004581646144173751
	accuse product	0.00036160450245141415
	sale	0.00035131254083996624
	secondary consideration	0.0002805715150601557
	turn	0.00024564957271559605
	every asserted	0.00020293167485530613
	method	0.00019285154789402826
	en banc	0.00017759908971695779
	failure	0.00015547652249979773
	place	0.00013809654155805265
	lack	0.00011352734850621687
	context	0.00011311244297944734
	language	9.626218052775486e-05
	ordinary skill	8.443680678576497e-05
	broad term	6.069540417439023e-05
	holding	5.333499725390793e-05
	clearly erroneous finding	5.299399888049143e-05
	specific purpose	5.2134229333332644e-05
	background	5.190246711067492e-05
	jurisdiction	4.40098207883664e-05
	final judgment	4.3507531732450275e-05
	underlie factual question	4.221011401359548e-05
	four prior art	3.9801452262880216e-05
	de novo	3.623695663936575e-05
	party assert invalidity	3.2031196898682985e-05
	know element	3.071598578328178e-05
	obviousness analysis	3.0150207222629353e-05
	favor	2.946820679066276e-05
	clear error	2.7554887681932708e-05
	Claim	2.4828736283930536e-05
	difference	1.0312696805189716e-05
	patentee	6.428425481970976e-06
	Idaho	5.5847852333024835e-06
	subject matter	4.346321707600166e-06
	order	4.286749934515281e-06
	scope	3.089467403776609e-06
	light	2.6711519664461356e-06
	district court infringement determination	8.688177511300819e-07
	district court decision	8.636088146825029e-07
	prior art reference	6.778394511051418e-07
	application	4.426040353039921e-07
	evidence	2.2568960448732855e-07
	state	2.1754466945609566e-07
	infringement action	8.16565863108271e-08
	case law	4.3542120600772774e-08
	issue	1.6027975083042185e-09
	Court	0.0
	Appeals	0.0
	Fed	0.0
